This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Vibrio vulnificus Cytolysin (vvhA), C-His
Product Overview
BioVenic's Recombinant Vibrio vulnificus Cytolysin (vvhA), C-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 51.9 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Vibrio vulnificus cytolysin (vvhA) is a pore-forming toxin that plays a crucial role in the pathogenesis of infections caused by this marine bacterium. In veterinary medicine, understanding the function of VvhA can help in the development of strategies to prevent and treat infections in animals, particularly those at risk of exposure to environments where V. vulnificus is prevalent, such as aquatic animals. VvhA's cytotoxic effects can lead to tissue damage and severe disease outcomes, making it a key target for diagnostic and therapeutic interventions.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.